Cédric Cleyrat, PhD
About Cédric Cleyrat, PhD
Cédric Cleyrat, PhD, is the Senior Scientific Director at Bristol Myers Squibb in Seattle, Washington, and a Board Member at the French-American Chamber of Commerce of the Pacific Northwest.
Title and Current Position
Cédric Cleyrat, PhD, currently holds the position of Senior Scientific Director at Bristol Myers Squibb in Seattle, Washington, United States. In addition to his role at Bristol Myers Squibb, he serves as a Board Member at the French-American Chamber of Commerce of the Pacific Northwest, also based in Seattle, Washington.
Professional Background
Cédric Cleyrat has an extensive professional background in the field of oncology and cell therapy. Prior to his current role, he served as Scientific Director at Bristol Myers Squibb from 2021 to 2023 and as Associate Director from 2020 to 2021. His previous positions include Principal Scientist and Senior Scientist Group Lead for Gene Editing & Discovery Research at Juno Therapeutics, Inc. He has also worked as a Consultant in Genome Editing Technologies at the University of New Mexico Comprehensive Cancer Center and held an academic position as an Assistant Research Professor at The University of New Mexico Health Sciences Center.
Education and Academic Credentials
Cédric Cleyrat earned a Ph.D. in Hematology & Oncology from Nantes Université, where he researched Cellular & Molecular Biology of Myeloid Malignancies. He holds multiple advanced degrees including an M.S. in Cellular & Molecular Biology, Biochemistry, and Bio-Organic Chemistry from La Rochelle Université, and an M.S. in Biotechnologies, Bioindustries, and Bioprocesses from La Rochelle Institute of Technology & ESC Business School. Cleyrat also completed a B.S. in Structural Biology and an Associate's Degree in Biological Engineering and Biotechnologies from La Rochelle Université.
Research and Development Contributions
At Bristol Myers Squibb, Cédric Cleyrat leads the development and implementation of non-viral delivery methods for cell therapy. He oversees the biological validation of engineering strategies for cell therapeutics, collaborating with internal and external partners to identify new platforms and opportunities. Cleyrat focuses on the integration of novel delivery and cell engineering concepts to support early process development and ensures the seamless transition from research and development to manufacturing for novel cell therapy engineering platforms.
Past Research Roles
Earlier in his career, Cédric Cleyrat worked as a Postdoctoral Researcher at the University of New Mexico Dept. of Pathology & Systems Biology Center (STMC). He also served as a Doctoral Researcher at Inserm - University of Nantes and worked as a Graduate Research And Teaching Assistant at Nantes Université. These roles were fundamental in shaping his expertise in cellular and molecular biology, particularly in the area of hematology and oncology.